<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF0020F8-9212-4670-ADC0-CBDFF5B93548"><gtr:id>DF0020F8-9212-4670-ADC0-CBDFF5B93548</gtr:id><gtr:name>GlaxoSmithKline</gtr:name><gtr:address><gtr:line1>Stockley Park West</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:postCode>UB11 1BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BAFEC7F8-6D49-48AC-9AF2-919CBB9421A7"><gtr:id>BAFEC7F8-6D49-48AC-9AF2-919CBB9421A7</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Stockman</gtr:surname><gtr:orcidId>0000-0002-7915-340X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FF068352%2F1"><gtr:id>76818F21-8894-4E1E-91CA-456BDBA6B711</gtr:id><gtr:title>New Multi-Component Reactions For Array Synthesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/F068352/1</gtr:grantReference><gtr:abstractText>The project will develop new methods for so-called Multi-Component Reactions which will be able to generate arrays of amines and sulfonamides with a stereogenic (handed) centre next to the nitrogen functionality with complete control over each and every group attached to the nitrogen and the adjacent stereogenic carbon. The method will bring together up to six components in one reaction vessel to give single products in a predictable and controlled manner. By varying the six components any one of a huge number of potential chiral amines can be accessed, therefore allowing medicinal chemists easy access to either large numbers of chiral amines or specific sub-sets of chiral amines with ease and accuracy.</gtr:abstractText><gtr:fund><gtr:end>2011-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>305870</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>A number of chiral amines were made for GlaxoSmithKline</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>D074C2B2-5304-418E-97C6-8EEF6213D041</gtr:id><gtr:impactTypes/><gtr:outcomeId>5460dda80cb512.16570096</gtr:outcomeId><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We discovered a general, one-pot synthesis of chiral amines which does not require chromatography.</gtr:description><gtr:exploitationPathways>Used to make chiral amines for the fine chemicals or pharmaceutical industry.</gtr:exploitationPathways><gtr:id>C483986E-0317-44B8-AB2D-49A94219825F</gtr:id><gtr:outcomeId>5460de39a19f71.06356956</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>39BE9437-5BC3-46D0-AD17-4D62C20E111E</gtr:id><gtr:title>On the utility of S-mesitylsulfinimines for the stereoselective synthesis of chiral amines and aziridines.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88c69e1ac71727b1dd59a21bbcfbc320"><gtr:id>88c69e1ac71727b1dd59a21bbcfbc320</gtr:id><gtr:otherNames>Roe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>543bd0cf71a064.82691523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1195FD4C-DBD5-4698-846F-B85620A30580</gtr:id><gtr:title>Multicomponent synthesis of chiral sulfinimines.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88c69e1ac71727b1dd59a21bbcfbc320"><gtr:id>88c69e1ac71727b1dd59a21bbcfbc320</gtr:id><gtr:otherNames>Roe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>543bd0cfa5b656.98471536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89FB1FAB-C9F5-47D9-A907-8CD4BFD48AD7</gtr:id><gtr:title>One-pot synthesis of chiral nonracemic amines.</gtr:title><gtr:parentPublicationTitle>The Journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88c69e1ac71727b1dd59a21bbcfbc320"><gtr:id>88c69e1ac71727b1dd59a21bbcfbc320</gtr:id><gtr:otherNames>Roe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3263</gtr:issn><gtr:outcomeId>543bd0cf402405.51674547</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/F068352/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D59C2DC2-AD17-4980-92F3-677EB001B765</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Combinatorial Chemistry</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>